Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 40,122 shares at $24.91 ($1.0M) on 2022-03-04, disclosed to the SEC on 2022-03-09.
Seasonal sale ($1.0M) by Chief Scientific & Med Officer — this insider has traded VCYT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.91 | 17,089 | $426K | 42.4% |
| 2 | $24.91 | 17,089 | $426K | 42.4% |
| 3 | $25.70 | 5,844 | $150K | 15.0% |
| 4 | $26.49 | 100 | $3K | 0.3% |
| Total | $25.03 avg | 40,122 | $1.0M | 100% |
| Filing → |
| VCYT | SELL | 2022-11-08 | $26K | — | Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-07 | $425K | — | Filing → |